The 2021 Cardiovascular Nursing Symposium will be held virtually over the course of three events. You can register to attend the Pharmacology Course, the General Sessions, and/or the Skill Building Workshop. Learn more about registration options.

All CE sessions will be recorded and made available to registrants exclusively until September 7, 2021. Whether you attend live or view the recordings, you’ll have the opportunity to earn up to 16.5 CE contact hours, including 5.0 pharmacology.

Skill Building Workshop

3.0 CE contact hours
8:00 AM CTWelcome
8:10 AM CTInterpreting and Applying the 12 Lead ECG in Clinical Settings
Caroline Miller Reilly, PhD, RN, CFHN
9:10 AM CTBreak
9:20 AM CTInterpreting and Applying the 12 Lead ECG in Clinical Settings continued
10:20 AM CTBreak
10:30 AM CTHeart Sounds: What is Your Patient's Heart Telling You?
Jane Linderbaum, MS, CNP, AACC
11:30 AM CTProduct Theater
12:15 PM CTAdjourn
Friday, May 7
2.0 CE contact hours
8:00 AM CTWelcome
8:15 AM CTBehavior change principles in action: Helping Patients Set Goals and Follow a Heart-Healthy Eating Plan
Geeta Sikand, MA, RDN, FAND, CDE, CLS, FNLA
9:15 AM CTBehavior Change Principles in Action: Improving Medication Adherence
Dr. Eric Coleman
10:15 AM CTBreak
10:30 AM CTIdentification and Management of Sleep Apnea to Reduce CVD Risk
Lisa Maher, DNP, ARNP, FNP-BC
11:15 AM CTAdjourn

Pharmacology Course

4.0 CE contact hours, including 4.0 pharmacology
9:00 AM CTWelcome
9:15 AM CTThe Science and Clinical Application of Cannabinoids
Theresa Mallick-Searle MS, RN-BC, ANP-BC
10:15 AM CTPharmacologic Management of Depression in Adults with CVD
Michelle Heyland DNP, APN, PMHNP-BC
11:15 AM CTBreak
11:30 AM CTPharmacologic Management of Patients with Complex Co-Morbidities: Preventing the Progression of CKD
Carol Headley DNS, ACNP
12:30 AM CTThyroid Disorder and its Relationship to Cardiovascular Diseases
Michele Merten, APRN, CNP, DNP
1:30 PM CTBreak
1:45 PM CTReducing LDL-C and Cardiovascular Risk With PCSK9 Inhibitors
Margo B. Minissian, PhD, ACNP, NEA-BC, FNLA, FAHA
2:45 PM CTWrap Up

General Sessions

3.75 CE contact hours
8:00 AM CTWelcome
8:15 AM CTAmgen, Inc. Disease State Theater
Topic: Dyslipidemia
9:00 AM CTVirtual Posters Break
9:15 AM CTOpening Keynote: CVD Prevention and Management: Top 5 Trials of 2020/2021
Karol Watson, MD
10:15 AM CTCOVID-19 and CVD: What have we learned?
Yvonne Commodore Mensah RN, PhD
11:00 AM CTVirtual Exhibit Hall and Posters Break
11:15 AM CTOral Poster Presentations
11:45 AM CTTelehealth and Virtual Patient Care: Best Practices
Kelli Garber MSN, APRN, PPCNP-BC
12:30 PM CTVirtual Exhibit Hall and Posters Break
1:00 PM CTEsperion Therapeutics Product Theater
An Approach to Managing Lipids: Oral, Nonstatin Therapies for Lowering LDL-C
1:45 PM CTHonorary Fellow Keynote: Challenge of CVD Risk Reduction in Racial and Ethnic Minorities
Keith Ferdinand MD
2:30 PM CTAwards Ceremony
2:45 PM CTVirtual Exhibit Hall Open
3.75 CE contact hours, including 1.0 pharmacology
8:00 AM CTWelcome
8:15 AM CTThe Treatment of Heart Failure in 2021; New Discoveries & New Data
Time to Change the Paradigm
Clyde W. Yancy, MD, MSc, MACC, FAHA MACP, HFSA
9:00 AM CTVirtual Posters Break
9:15 AM CTManaging Stable Coronary Artery Disease: Invasive vs Conservative Approach
David Maron MD
9:45 AM CTCan Stenting Prevent MI in Stable CHD?
William Fearon MD
10:15 AM CTCases: Lifestyle, Medication and Intervention to Manage Stable CHD
David Maron, MD and William Fearon, MD
10:45 AM CTVirtual Exhibit Hall and Posters Break
11:00 PM CTBest Practices in Stroke Prevention: Risk Factor Management or Surgery?
Thomas Brott MD
11:45 PM CTSubstance Abuse and Cardiovascular Disease
Mariann Piano, RN, PhD
12:30 PM CTVirtual Exhibit Hall and Posters Break
1:00 PM CTAmgen, Inc. Product Theater
Topics: Dyslipidemia
Jan Mcalister, NP
1:45 PM CTClosing Keynote: Fearless Soul: The Call to Nursing and the Courage to Stay
Elizabeth Ann Robinson, PhD, RN, CNS
2:45 PM CTVirtual Exhibit Hall Open


This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). Multiple educational grants have been requested to support this program. PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. This program was planned in accordance with AANP CE Policies and Commercial Support Standards.